Another milestone for Onconase
Thursday, March 30th, 2006Alfacell Corp., the New Jersey pharmaceutical company, got enough patients to go ahead with phase IIIb testing on Onconase, (ranpirnase). Another step in the long process toward getting approval for that drug, which is promising in mesothelioma treatment. The drug companies sometimes target mesothelioma in their development process even though it is a [...]
